SNGX logo
SNGX NASDAQ US

Soligenix, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Apr 1994
$1.14
▼ $-0.01 (-0.87%)
Vol 373K
2
Quality Score
fail
Mkt Cap
$13.5M
ROE
-267.1%
Margin
-1424.5%
D/E
0.00
Beta
2.08
52W
$1–$6

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

BCDA
BioCardia Inc
$13.3M
MBRX
Moleculin Biotech Inc
$6.8M
IMNN
Imunon Inc
$11.7M
CLRB
Cellectar Biosciences Inc
$12.5M
BIVI
BioVie Inc
$8.7M
ACXP
Acurx Pharmaceuticals Inc
$5.8M

Earnings

Beat rate: 40.0%
Next Report May 07, 2026
EPS Estimate: $-0.27
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.27 — —
Dec 2025 $-0.57 $-0.28 +$0.29
Sep 2025 $-0.57 $-0.58 $-0.01
Jun 2025 $-0.94 $-0.82 +$0.12

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -274.8% -223.9% -274.8% -274.8% -274.8% -267.1%
P/E (TTM) — — — — — —
Net Margin — -1424.5% -1424.5% -1424.5% -1424.5% -1424.5%
Gross Margin — 8.8% 8.8% 8.8% 8.8% 8.8%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.47 1.85 1.47 1.47 1.47 3.18

Key Ratios

ROA (TTM)
-135.7%
P/S (TTM)
27.35
P/B
1.6
EPS (TTM)
$-3.66
CF/Share
$-1.38
Rev Growth 3Y
-47.4%
52W High
$6.23
52W Low
$1.09
$1.09 52-Week Range $6.23

How does SNGX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SNGX AAPG ABEO ABOS ABP

SNGX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
27.4
▲ 113% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.6
▼ 33% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SNGX profitability vs Biotechnology peers

ROE
-267.1%
▼ 297% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-1424.5%
▼ 397% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
8.8%
▼ 89% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-135.7%
▼ 191% below peers (-46.7%)
vs Peers
vs Industry
Weak

SNGX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.2
▼ 28% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.1
▲ 114% above peers (1.0)
vs Peers
vs Industry
More volatile

SNGX fundamentals radar

SNGX Peer median Industry

SNGX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SNGX vs peers: key metrics

Latest News

No related news yet